We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.6B
AUM Growth
-$2.31B
(-5.8%)
Cap. Flow
-$309M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
3,035
New
443
Increased
1,011
Reduced
1,232
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$465M |
| 2 |
Amazon
AMZN
|
+$304M |
| 3 |
Apple
AAPL
|
+$297M |
| 4 |
Occidental Petroleum
OXY
|
+$286M |
| 5 |
Zoom
ZM
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$395M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$373M |
| 3 |
Caterpillar
CAT
|
+$297M |
| 4 |
Intel
INTC
|
+$277M |
| 5 |
NVIDIA
NVDA
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.58% |
| 2 | Healthcare | 20.45% |
| 3 | Consumer Discretionary | 10.84% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Airgain
AIRG
$73.4M
| $253K | ﹤0.01% |
33,375
-4,143
| -11% | -$37.9K |
|
|
STSA
2302
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $253K | ﹤0.01% |
66,600
-21,400
| -24% | -$96.4K |
|
|
TREC
2303
DELISTED
Trecora Resources
TREC
| $253K | ﹤0.01% |
29,900
-15,900
| -35% | -$136K |
|
2304
Standard BioTools
LAB
$340M
| $252K | ﹤0.01% |
70,300
+3,600
| +5% | +$12.4K |
|
2305
Ferguson
FERG
$45.4B
| $250K | ﹤0.01% |
+1,863
| New | +$287K |
|
|
CLLS
2306
Cellectis
CLLS
$277M
| $249K | ﹤0.01% |
+54,800
| New | +$302K |
|
2307
Powell Industries
POWL
$7.6B
| $249K | ﹤0.01% |
38,424
-21,600
| -36% | -$177K |
|
|
AQUA
2308
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $249K | ﹤0.01% |
+5,300
| New | +$226K |
|
2309
Princeton Bancorp
BPRN
$281M
| $248K | ﹤0.01% |
8,600
-100
| -1% | -$2.99K |
|
2310
Navigator Holdings
NVGS
$1.38B
| $248K | ﹤0.01% |
20,300
+2,900
| +17% | +$29.2K |
|
2311
Precision BioSciences
DTIL
$180M
| $247K | ﹤0.01% |
2,677
+1,570
| +142% | +$213K |
|
2312
Ligand Pharmaceuticals
LGND
$5.76B
| $247K | ﹤0.01% |
3,527
+481
| +16% | +$34.9K |
|
2313
Akebia Therapeutics
AKBA
$354M
| $244K | ﹤0.01% |
339,449
-61,200
| -15% | -$131K |
|
2314
HighPeak Energy
HPK
$903M
| $244K | ﹤0.01% |
+11,000
| New | +$216K |
|
|
LILM
2315
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $244K | ﹤0.01% |
61,400
+39,600
| +182% | +$183K |
|
2316
China Yuchai International
CYD
$1.77B
| $243K | ﹤0.01% |
20,890
+9,600
| +85% | +$124K |
|
2317
Intellicheck
IDN
$73.1M
| $243K | ﹤0.01% |
95,400
+84,000
| +737% | +$306K |
|
|
ATIP
2318
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $243K | ﹤0.01% |
+2,582
| New | +$329K |
|
2319
Cibus
CBUS
$147M
| $242K | ﹤0.01% |
4,652
-3,210
| -41% | -$240K |
|
2320
Live Ventures
LIVE
$29.8M
| $241K | ﹤0.01% |
+5,500
| New | +$179K |
|
2321
Broadstone Net Lease
BNL
$4.11B
| $240K | ﹤0.01% |
+11,000
| New | +$246K |
|
2322
Cadiz
CDZI
$251M
| $240K | ﹤0.01% |
115,800
-500
| -0.4% | -$1.26K |
|
|
CMRX
2323
DELISTED
Chimerix, Inc.
CMRX
| $240K | ﹤0.01% |
52,400
-333,900
| -86% | -$1.86M |
|
2324
Cyclerion Therapeutics
CYCN
$14.9M
| $239K | ﹤0.01% |
10,755
-15,315
| -59% | -$369K |
|
|
PRSU
2325
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
| $239K | ﹤0.01% |
6,700
-3,000
| -31% | -$110K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Advisers held 3,035 positions worth $37.6B, down 5.8% from $39.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q1 2022 filing shows 443 new, 1,011 increased, 1,232 reduced and 320 closed positions. Its largest new stake was PepsiCo: 1,100,300 shares worth $184M. The largest sale was Coca-Cola, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Two Sigma Advisers's largest Q1 2022 buy was PepsiCo: 1,100,300 shares worth $184M.
- Two Sigma Advisers added most to Adobe in Q1 2022, an estimated $465M increase.
- Two Sigma Advisers's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $395M.
- Two Sigma Advisers fully exited Activision Blizzard in Q1 2022, selling an estimated $373M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $37.6B portfolio in Q1 2022.
- Two Sigma Advisers opened 443 new positions and closed 320 in Q1 2022.
- Two Sigma Advisers's portfolio value fell 5.8% quarter-over-quarter to $37.6B.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.